This safety signal was likely contributed by a few measures, such as patient education on hypoglycemia recognition and management at the time of enrollment, along with automated alerts with algorithm-guided insulin dosing suggestions to the treating physician via the ALRT app in event of hypoglycemia, prompting timely adjustment of insulin doses ahead of the scheduled weekly SMBG reviews. This evidence concerns the gene INS and Hypoglycemia.